HIND logo

Vyome Holdings, Inc. Stock Price

NasdaqCM:HIND Community·US$29.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

HIND Share Price Performance

US$5.31
-8.69 (-62.07%)
US$5.31
-8.69 (-62.07%)
Price US$5.31

HIND Community Narratives

There are no narratives available yet.

Snowflake Analysis

Medium-low risk with limited growth.

6 Risks
2 Rewards

Vyome Holdings, Inc. Key Details

US$394.5k

Revenue

US$116.0k

Cost of Revenue

US$278.5k

Gross Profit

US$1.7m

Other Expenses

-US$1.5m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.27
70.60%
-369.35%
-89.3%
View Full Analysis

About HIND

Founded
2017
Employees
18
CEO
Venkateswarlu Nelabhotla
WebsiteView website
www.vyometx.com

Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Cambridge, Massachusetts.

Recent HIND News & Updates

Recent updates

No updates